Literature DB >> 35288881

Postpartum reclassification test in gestational diabetes: can the test be reduced to 1 hour?

Mariana Barbosa1, Patrícia Moreira Gomes2, Ana Margarida Monteiro3, Catarina Matos3, Maria Lopes Pereira3, Vera Fernandes3.   

Abstract

PURPOSE: In gestational diabetes mellitus (GDM), a postpartum oral glucose tolerance test (OGTT) is recommended. However, poor adherence to this procedure has been described, and the time required is one of the reasons. Our aims were to identify predictive factors for abnormal 2-h reclassification OGTT values, including OGTT 1-h glucose, and, if it was a factor, to determine the 1-h cutoff point that best identifies abnormal values at 2 h.
METHODS: This was a retrospective study of 769 patients diagnosed with GDM between 2014 and 2019 in a tertiary center. The sample was divided into two groups according to the presence/absence of abnormal 2-h reclassification values, and predictive factors were studied. To determine the 1-h glycemia cutoff point capable of identifying 2-h changes, a ROC curve was drawn and the Youden index was used.
RESULTS: The mean age of included women was 33.6 ± 4.95 years: 70 of them (9.1%) had an abnormal 2-h test result. Women with a history of GDM (OR = 3.41, p = .012) and higher 1-h glycemia value (OR = 1.05, p < .001) had a higher risk of developing an abnormal 2-h test result. One-hour glycemia ≥ 142 mg/dL had a sensitivity of 91.4% and specificity of 75.1% to identify changes in the test at 2 h; area under the curve to predict 2-h changes was 0.90 (CI 95%: 0.86 - 0.93).
CONCLUSION: Glucose measurement at 1 h predicts alterations at 2 h in the reclassification test with excellent diagnostic accuracy, and the cutoff point of  ≥ 142 mg/dL presents high sensitivity. These findings could serve as a foundation for a possible future redefinition of the OGTT procedure, but further investigation is required.
© 2022. Hellenic Endocrine Society.

Entities:  

Keywords:  1-h plasma glucose; Accuracy; Cutoff point; Postpartum oral glucose tolerance test

Mesh:

Substances:

Year:  2022        PMID: 35288881     DOI: 10.1007/s42000-022-00359-w

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  2 in total

1.  Screening for type 2 diabetes following gestational diabetes: family physician and patient perspectives.

Authors:  Erin Keely; Heather Clark; Alan Karovitch; Ian Graham
Journal:  Can Fam Physician       Date:  2010-06       Impact factor: 3.275

2.  [Diabetes in pregnancy - postpartum screening].

Authors:  Ana Carocha; Cláudia Rijo; Njila Amaral; Francisca Aleixo; Tiago Rocha
Journal:  Acta Med Port       Date:  2012-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.